Back
HFA Premium Access

Safety profile of novel angiotensin II type-1 receptor neprilysin inhibitor lcz696 (sacubitril/valsartan) - a collaborative summary from clinical trials

Session: Poster Session 4 - Chronic Heart Failure – Treatment
Topic: Pharmacotherapy
Speaker: Doctor A. Barano (Kapuas Hulu, ID)
Event: Heart Failure 2018

Congress Presentation

About the speaker

Doctor Adhiala Zyggo Barano

Badau Bergerak Hospital, Kapuas Hulu (Indonesia)
0 follower

21 more presentations in this session

Comparison of therapeutic effects between urapidil and nitroglycerin for treatment of acute heart failure with hypertension and atrial fibrillation in elderly patients

Speaker: Professor Q. Hua (Beijing, CN)

Access
Abstract
Thumbnail

Obstacles to mineralocorticoid receptor antagonists in a community based heart failure population

Speaker: Mrs H. Norberg (Umea, SE)

Access
Abstract
Slides
Thumbnail

Prognostic value of diuretic dose in stable chronic heart failure

Speaker: Doctor L. Lupi (Brescia, IT)

Access
Abstract
Thumbnail

Two-years outcome of patients with heart failure and severe left ventricular dysfunction treated with ivabradine and low doses of beta-blocker

Speaker: Doctor F. Melillo (Milan, IT)

Access
Abstract
Thumbnail

Effectiveness of Sacubitril/Valsartan in real-life practice: experience of a single center

Speaker: Doctor J. Neiva (Viana do Castelo, PT)

Access
Abstract
Thumbnail

Access the full session

Poster Session 4 - Chronic Heart Failure – Treatment

Speakers: Doctor A. Barano, Professor Q. Hua, Mrs H. Norberg, Doctor L. Lupi, Doctor F. Melillo...
Access
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources